Jennifer Brady

Jennifer Brady currently serves as the Director of Biology at Variant Bio, where responsibilities include identifying new pipeline targets, drafting validation proposals, leading collaborative preclinical studies, and mentoring team members. Previously, as Senior Scientist at 23andMe, Jennifer led target discovery workstreams across various diseases, contributing to over 12 project proposals and managing a team of scientists. Experience also includes roles at Surrozen, where Jennifer advanced lead molecule characterization, and at Stanford University, where research focused on tumor progression and gene expression modulation. Jennifer holds a PhD in Microbiology and Immunology from Stanford University and dual Bachelor's degrees in Biological Sciences and Chemistry from Cornell University.